AUSTIN, TX / ACCESSWIRE / April 1, 2019 / Savara Inc. (SVRA), an orphan lung disease company, today announced the initiation of ENCORE, a Phase 2a clinical study evaluating its lead product candidate, ...

AUSTIN, TX--(Marketwired - October 24, 2017) - Savara Inc. (SVRA), an orphan lung disease company, today announced its indication expansion strategy of its lead product candidate Molgradex, an inhaled ...

The Baylor Medicine NTM Infection Program brings together specialists that can help you identify, understand, and manage NTM lung infections. As a leading center for comprehensive NTM care, we aim to ...

Nontuberculous mycobacterial (NTM) lung disease is a chronic and debilitating condition, and although considered rare, some studies have estimated that prevalence is increasing about 8% each year in ...

GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the ...

Nontuberculous mycobacteria (NTM) are mycobacteriaceae species that can cause the onset of illness in humans. NTM are present naturally in the soil and air. But NTM are not the causative agents of ...

RHB-204 Phase 3 study in pulmonary NTM infections is planned to be initiated in the coming weeks--Orphan Drug Designation, along with RHB-204’s FDA QIDP priority designation, will extend U.S.

BRIDGEWATER, N.J., July 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...

RHB-204 Orphan Drug designation and QIDP designation extend potential market exclusivity up to 12 years post-approval and provide eligibility for Fast-Track development and NDA Priority Review TEL ...

Those results demonstrated that the addition of ALIS to GBT eliminated evidence of NTM lung disease caused by MAC in sputum by Month 6 in 29% of patients, compared to 9% of patients on GBT only (p ...

Patients with rheumatic disease are at a higher risk of infection than the general population. Studies have focused mainly on the infection risk associated with the treatment of rheumatic disease. 1 ...